Vor Ort
Merkzettel Warenkorb
  • Produktbild: Improved Non-Steroid Anti-Inflammatory Drugs: COX-2 Enzyme Inhibitors
  • Produktbild: Improved Non-Steroid Anti-Inflammatory Drugs: COX-2 Enzyme Inhibitors

Improved Non-Steroid Anti-Inflammatory Drugs: COX-2 Enzyme Inhibitors

97,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

25.12.2011

Herausgeber

Sir John R. Vane + weitere

Verlag

Springer Netherland

Seitenzahl

200

Maße (L/B/H)

23,5/15,5/1,5 cm

Auflage

Softcover reprint of the original 1st ed. 1996

Sprache

Englisch

ISBN

978-94-010-9031-5

Beschreibung

Portrait

Sir John Vane is the Director General at the William Harvey Research Institute, an independent charitable foundation within Queen Mary and Westfield College of the University of London, UK.

Sir John Vane shared the Nobel Prize in Physiology or Medicine in 1982 for his discoveries of the mechanism of action of aspirin and of prostacyclin, as well as his work on other prostanoids. Jack Botting is Consultant at the William Harvey Research Institute, an independent charitable foundation within Queen Mary and Westfield College of the University of London, UK.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

25.12.2011

Herausgeber

Verlag

Springer Netherland

Seitenzahl

200

Maße (L/B/H)

23,5/15,5/1,5 cm

Auflage

Softcover reprint of the original 1st ed. 1996

Sprache

Englisch

ISBN

978-94-010-9031-5

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Improved Non-Steroid Anti-Inflammatory Drugs: COX-2 Enzyme Inhibitors
  • Produktbild: Improved Non-Steroid Anti-Inflammatory Drugs: COX-2 Enzyme Inhibitors
  • Preface. 1. Overview - Mechanisms of Action of Anti-Inflammatory Drugs; J. Vane, R. Botting. 2. The Three-Dimensional Structure of Cyclooxygenases; R.M. Garavito. 3. The Dilemma of Two Cyclooxygenases: Identifying the Roles of COX-1 and COX-2 in Inflammation and Apoptosis; D. Simmons, et al. 4. Inducible Enzymes with Special Reference to COX-2 in the Inflammatory Response; D. Willoughby, et al. 5. NSAID Mechanism of Action: The Role of Intracellular Pharmacokinetics; L. Herbette, et al. 6. Differential Inhibition of COX-1 and COX-2 in vitro and Pharmacological Profile in vivo of NSAIDs; M. Pairet, G. Engelhardt. 7. COX-2 Expression and Inhibition in Human Monocytes; C. Patrono, et al. 8. Expression and Regulation of COX-2 in Synovial Tissues of Arthritic Patients; L. Crofford. 9. An Inhibitor of Injury-Induced COX-2 Transcriptional Activation Elicits Neuroprotection in a Brain Damage Model; N. Bazan, G. Allan. 10. COX-2 Expression in Labour; P. Bennett, D. Slater. 11. Re-Evaluation of Gut Toxicity of NSAIDs; D.N. Bateman. 12. NSAID: Can Renal Side Effects be Avoided? J. Frölich, D. Stichtenoth. 13. Pharmacology, Safety Data and Therapeutics of COX-2 Inhibitors; P. Emery. Index.